88 related articles for article (PubMed ID: 18269913)
1. The effects of anthrax lethal factor on the macrophage proteome: potential activity on nitric oxide synthases.
Kim J; Park H; Myung-Hyun J; Han SH; Chung H; Lee JS; Park JS; Yoon MY
Arch Biochem Biophys; 2008 Apr; 472(1):58-64. PubMed ID: 18269913
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analyses of murine macrophages treated with Bacillus anthracis lethal toxin.
Sapra R; Gaucher SP; Lachmann JS; Buffleben GM; Chirica GS; Comer JE; Peterson JW; Chopra AK; Singh AK
Microb Pathog; 2006; 41(4-5):157-67. PubMed ID: 16950595
[TBL] [Abstract][Full Text] [Related]
3. Differential susceptibility of macrophage cell lines to Bacillus anthracis-Vollum 1B.
Gutting BW; Gaske KS; Schilling AS; Slaterbeck AF; Sobota L; Mackie RS; Buhr TL
Toxicol In Vitro; 2005 Mar; 19(2):221-9. PubMed ID: 15649636
[TBL] [Abstract][Full Text] [Related]
4. Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude mice.
Abi-Habib RJ; Singh R; Leppla SH; Greene JJ; Ding Y; Berghuis B; Duesbery NS; Frankel AE
Clin Cancer Res; 2006 Dec; 12(24):7437-43. PubMed ID: 17189417
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing monoclonal antibody against anthrax lethal factor inhibits intoxication in a mouse model.
Zhao P; Liang X; Kalbfleisch J; Koo HM; Cao B
Hum Antibodies; 2003; 12(4):129-35. PubMed ID: 15156101
[TBL] [Abstract][Full Text] [Related]
6. Chemical genetic screening identifies critical pathways in anthrax lethal toxin-induced pathogenesis.
Panchal RG; Ruthel G; Brittingham KC; Lane D; Kenny TA; Gussio R; Lazo JS; Bavari S
Chem Biol; 2007 Mar; 14(3):245-55. PubMed ID: 17379140
[TBL] [Abstract][Full Text] [Related]
7. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
Sloat BR; Shaker DS; Le UM; Cui Z
FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342
[TBL] [Abstract][Full Text] [Related]
8. Manipulation of host signalling pathways by anthrax toxins.
Turk BE
Biochem J; 2007 Mar; 402(3):405-17. PubMed ID: 17313374
[TBL] [Abstract][Full Text] [Related]
9. The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.
Rouleau C; Menon K; Boutin P; Guyre C; Yoshida H; Kataoka S; Perricone M; Shankara S; Frankel AE; Duesbery NS; Vande Woude G; Biemann HP; Teicher BA
Int J Oncol; 2008 Apr; 32(4):739-48. PubMed ID: 18360701
[TBL] [Abstract][Full Text] [Related]
10. Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs: analysis of the intracellular consequences in macrophages.
Pellizzari R; Guidi-Rontani C; Vitale G; Mock M; Montecucco C
Int J Med Microbiol; 2000 Oct; 290(4-5):421-7. PubMed ID: 11111921
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of Bacillus anthracis protective antigen observed in a macrophage cell line overexpressing ANTXR1.
Salles II; Voth DE; Ward SC; Averette KM; Tweten RK; Bradley KA; Ballard JD
Cell Microbiol; 2006 Aug; 8(8):1272-81. PubMed ID: 16882031
[TBL] [Abstract][Full Text] [Related]
12. Biological and biochemical characterization of anthrax lethal factor, a proteolytic inhibitor of MEK signaling pathways.
Bromberg-White JL; Duesbery NS
Methods Enzymol; 2008; 438():355-65. PubMed ID: 18413261
[TBL] [Abstract][Full Text] [Related]
13. Proteasome activity is required for anthrax lethal toxin to kill macrophages.
Tang G; Leppla SH
Infect Immun; 1999 Jun; 67(6):3055-60. PubMed ID: 10338520
[TBL] [Abstract][Full Text] [Related]
14. Decreased glycogen synthase kinase 3-beta levels and related physiological changes in Bacillus anthracis lethal toxin-treated macrophages.
Tucker AE; Salles II; Voth DE; Ortiz-Leduc W; Wang H; Dozmorov I; Centola M; Ballard JD
Cell Microbiol; 2003 Aug; 5(8):523-32. PubMed ID: 12864812
[TBL] [Abstract][Full Text] [Related]
15. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.
Vitale G; Pellizzari R; Recchi C; Napolitani G; Mock M; Montecucco C
Biochem Biophys Res Commun; 1998 Jul; 248(3):706-11. PubMed ID: 9703991
[TBL] [Abstract][Full Text] [Related]
16. Effects of anthrax lethal toxin on human primary keratinocytes.
Koçer SS; Matic M; Ingrassia M; Walker SG; Roemer E; Licul G; Simon SR
J Appl Microbiol; 2008 Dec; 105(6):1756-67. PubMed ID: 19120626
[TBL] [Abstract][Full Text] [Related]
17. Sensitizing anthrax lethal toxin-resistant macrophages to lethal toxin-induced killing by tumor necrosis factor-alpha.
Kim SO; Jing Q; Hoebe K; Beutler B; Duesbery NS; Han J
J Biol Chem; 2003 Feb; 278(9):7413-21. PubMed ID: 12488448
[TBL] [Abstract][Full Text] [Related]
18. Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-kappaB pathways.
Jung WK; Choi I; Lee DY; Yea SS; Choi YH; Kim MM; Park SG; Seo SK; Lee SW; Lee CM; Park YM; Choi IW
Int J Biochem Cell Biol; 2008; 40(11):2572-82. PubMed ID: 18571461
[TBL] [Abstract][Full Text] [Related]
19. Protein expression pattern of murine macrophages treated with anthrax lethal toxin.
Jung KH; Seo GM; Yoon JW; Park KS; Kim JC; Kim SJ; Oh KG; Lee JH; Chai YG
Biochim Biophys Acta; 2008 Nov; 1784(11):1501-6. PubMed ID: 18657635
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of inducible nitric oxide synthase by Acanthopanax senticosus extract in RAW264.7 macrophages.
Lin QY; Jin LJ; Cao ZH; Xu YP
J Ethnopharmacol; 2008 Jul; 118(2):231-6. PubMed ID: 18486372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
